FATE
Price
$1.06
Change
+$0.12 (+12.77%)
Updated
Apr 11 closing price
Capitalization
121.47M
18 days until earnings call
TNYA
Price
$0.49
Change
+$0.05 (+11.36%)
Updated
Apr 11 closing price
Capitalization
71.55M
25 days until earnings call
Ad is loading...

FATE vs TNYA

Header iconFATE vs TNYA Comparison
Open Charts FATE vs TNYABanner chart's image
Fate Therapeutics
Price$1.06
Change+$0.12 (+12.77%)
Volume$1.45M
Capitalization121.47M
Tenaya Therapeutics
Price$0.49
Change+$0.05 (+11.36%)
Volume$1.3M
Capitalization71.55M
FATE vs TNYA Comparison Chart
Loading...
FATE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TNYA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
FATE vs. TNYA commentary
Apr 12, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FATE is a Hold and TNYA is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 12, 2025
Stock price -- (FATE: $1.06 vs. TNYA: $0.49)
Brand notoriety: FATE and TNYA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: FATE: 60% vs. TNYA: 33%
Market capitalization -- FATE: $121.47M vs. TNYA: $71.55M
FATE [@Biotechnology] is valued at $121.47M. TNYA’s [@Biotechnology] market capitalization is $71.55M. The market cap for tickers in the [@Biotechnology] industry ranges from $266.66B to $0. The average market capitalization across the [@Biotechnology] industry is $1.98B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

FATE’s FA Score shows that 1 FA rating(s) are green whileTNYA’s FA Score has 1 green FA rating(s).

  • FATE’s FA Score: 1 green, 4 red.
  • TNYA’s FA Score: 1 green, 4 red.
According to our system of comparison, both FATE and TNYA are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

FATE’s TA Score shows that 4 TA indicator(s) are bullish while TNYA’s TA Score has 5 bullish TA indicator(s).

  • FATE’s TA Score: 4 bullish, 4 bearish.
  • TNYA’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, TNYA is a better buy in the short-term than FATE.

Price Growth

FATE (@Biotechnology) experienced а +38.62% price change this week, while TNYA (@Biotechnology) price change was -1.18% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.15%. For the same industry, the average monthly price growth was -16.20%, and the average quarterly price growth was -17.21%.

Reported Earning Dates

FATE is expected to report earnings on Jul 30, 2025.

TNYA is expected to report earnings on Aug 06, 2025.

Industries' Descriptions

@Biotechnology (+0.15% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
FATE($121M) has a higher market cap than TNYA($71.6M). FATE YTD gains are higher at: -35.758 vs. TNYA (-65.531). TNYA has higher annual earnings (EBITDA): -107.48M vs. FATE (-176.58M). FATE has more cash in the bank: 279M vs. TNYA (61.4M). TNYA has less debt than FATE: TNYA (13.6M) vs FATE (85.3M). FATE has higher revenues than TNYA: FATE (13.6M) vs TNYA (0).
FATETNYAFATE / TNYA
Capitalization121M71.6M169%
EBITDA-176.58M-107.48M164%
Gain YTD-35.758-65.53155%
P/E RatioN/AN/A-
Revenue13.6M0-
Total Cash279M61.4M454%
Total Debt85.3M13.6M627%
FUNDAMENTALS RATINGS
FATE: Fundamental Ratings
FATE
OUTLOOK RATING
1..100
11
VALUATION
overvalued / fair valued / undervalued
1..100
15
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
94
PRICE GROWTH RATING
1..100
91
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
FATETNYA
RSI
ODDS (%)
Bullish Trend 1 day ago
81%
Bullish Trend 1 day ago
71%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
89%
Bullish Trend 1 day ago
82%
Momentum
ODDS (%)
Bullish Trend 1 day ago
80%
Bearish Trend 1 day ago
90%
MACD
ODDS (%)
Bullish Trend 1 day ago
83%
Bullish Trend 1 day ago
82%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
83%
Bearish Trend 1 day ago
90%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
85%
Bearish Trend 1 day ago
90%
Advances
ODDS (%)
Bullish Trend 3 days ago
84%
Bullish Trend 27 days ago
87%
Declines
ODDS (%)
Bearish Trend 12 days ago
90%
Bearish Trend 5 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
88%
Bullish Trend 1 day ago
90%
Aroon
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
View a ticker or compare two or three
Ad is loading...
FATE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TNYA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GTILX24.210.34
+1.42%
Glenmede Disciplined USGrEqPtf InstlShrs
ULPSX77.52N/A
N/A
ProFunds UltraBull Svc
BLNAX11.83N/A
N/A
Meeder Balanced Adviser
GQEPX20.78N/A
N/A
GQG Partners US Select Quality Eq Inv
IAFEX11.81N/A
N/A
Fisher IIG All Frgn Eq Env & Scl Val

TNYA and

Correlation & Price change

A.I.dvisor indicates that over the last year, TNYA has been loosely correlated with VCYT. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if TNYA jumps, then VCYT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TNYA
1D Price
Change %
TNYA100%
+12.02%
VCYT - TNYA
40%
Loosely correlated
+5.12%
RCUS - TNYA
34%
Loosely correlated
+9.07%
ABSI - TNYA
33%
Loosely correlated
+23.01%
OPT - TNYA
33%
Poorly correlated
N/A
FATE - TNYA
32%
Poorly correlated
+15.27%
More